image: Key markers of cardiometabolic health with increasing levels of linoleic acid in the blood, with higher levels generally linked to more favorable values compared to the lowest levels. Each bar shows the average value as a percentage of the group with the lowest linoleic acid levels. HOMA-IR: homeostasis model assessment for insulin resistance, hs-CRP: high-sensitivity C-reactive protein.
Credit: Carol F. Kirkpatrick and Kevin C. Maki
New research that used blood markers to measure linoleic acid levels and their relation to cardiometabolic risk adds evidence that this omega-6 fatty acid may help to lower risks for heart disease and type 2 diabetes. The findings challenge claims that seed oils are harmful to cardiometabolic health.
Linoleic acid, which is found in vegetable oils—especially seed oils like soybean and corn oil—and plant foods, is the primary omega-6 fatty acid consumed in the diet.
“There has been increasing attention on seed oils, with some claiming these oils promote inflammation and raise cardiometabolic risk,” said Kevin C. Maki, Ph.D., adjunct professor at the Indiana University School of Public Health-Bloomington and chief scientist at Midwest Biomedical Research. “Our study, based on almost 1,900 people, found that higher linoleic acid in blood plasma was associated with lower levels of biomarkers of cardiometabolic risk, including those related to inflammation.”
Maki will present the findings at NUTRITION 2025, the flagship annual meeting of the American Society for Nutrition held May 31–June 3 in Orlando.
The new results are consistent with those from observational studies that have shown higher intake of linoleic acid to be associated with lower risks for type 2 diabetes and cardiovascular events, such as heart attacks and strokes.
“Although other studies have assessed relationships between linoleic acid and cardiometabolic risk factors, our study used objective biomarkers rather than diet records or food frequency questionnaires to assess linoleic acid intake,” said Maki. “We also measured a range of markers of inflammation and indicators of glucose metabolism.”
For the new study, the investigators performed a cross-sectional analysis on data from 1,894 people in an observational cohort focused on Covid-19. They found that higher levels of linoleic acid in plasma—indicative of dietary intake—were consistently associated with lower levels of risk factors for cardiovascular disease and type 2 diabetes.
Specifically, study participants with higher linoleic acid showed lower levels of glucose and insulin as well as HOMA-IR, a biomarker of insulin resistance. They also had lower levels of inflammation biomarkers, including C-reactive protein, glycoprotein acetyls, and serum amyloid A.
“We saw consistent results across the different biomarkers measured,” Maki said. “People with higher levels of linoleic acid in their blood tended to have a healthier overall risk profile for heart disease and diabetes.”
The researchers say that their findings support the need for additional intervention studies to test whether increasing linoleic acid intake improves cardiometabolic risk factors and lowers the incidence of heart attacks, strokes and type 2 diabetes. Next, they plan to investigate how different types of oils with varying fatty acid content affect cardiometabolic risk factors.
Maki will present this research at 10:20-10:24 EDT on Sunday, June 1, during the Bioactives in Inflammation, Intestinal Health, Glucose and Bone Metabolism session (abstract; presentation details) and at 12:45-1:45 PM on Monday, June 2 during the Dietary Bioactive Components session (abstract; presentation details) in the Orange County Convention Center.
Please note that abstracts presented at NUTRITION 2025 were evaluated and selected by a committee of experts but have not generally undergone the same peer review process required for publication in a scientific journal. As such, the findings presented should be considered preliminary until a peer-reviewed publication is available.
About NUTRITION 2025
NUTRITION 2025 is the flagship meeting of the American Society for Nutrition and the premier educational event for nutritional professionals around the globe. NUTRITION brings together lab scientists, practicing clinicians, population health researchers and community intervention investigators to identify solutions to today’s greatest nutrition challenges. Our audience also includes rising leaders in the field – undergraduate, graduate and medical students. NUTRITION 2025 will be held May 31– June 3 in Orlando. https://nutrition.org/meeting/ #Nutrition2025
About the American Society for Nutrition (ASN)
ASN is the preeminent professional organization for nutrition research scientists and clinicians around the world. Founded in 1928, the society brings together the top nutrition researchers, medical practitioners, policy makers and industry leaders to advance our knowledge and application of nutrition. ASN publishes four peer-reviewed journals and provides education and professional development opportunities to advance nutrition research, practice, and education. Since 2018, the American Society for Nutrition has presented NUTRITION, the leading global annual meeting for nutrition professionals. http://www.nutrition.org
Find more news briefs from NUTRITION 2025 at: https://www.eurekalert.org/newsroom/nutrition2025.
###